Know Cancer

or
forgot password


N/A
18 Years
N/A
Not Enrolling
Female
Metastatic Breast Cancer

Thank you

Trial Information


Inclusion Criteria:



- Patients who participated on UMCC 9900/9901

- Living patients must give written informed consent

Exclusion Criteria:

- No tumor block tissue available

Type of Study:

Observational

Study Design:

Time Perspective: Retrospective

Principal Investigator

Anne F. Schott, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Michigan Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

UMCC 3-27

NCT ID:

NCT00146029

Start Date:

Completion Date:

Related Keywords:

  • Metastatic Breast Cancer
  • Patients who participated in UMCC 9900/9901 (Phase II Studies of Tailored-Dose Docetaxel in Metastatic Breast Cancer)
  • Breast Neoplasms

Name

Location

University of Michigan Cancer CenterAnn Arbor, Michigan  48109